Adverse effects | Sex | Age group in years (%) | Total (130) | ||||
---|---|---|---|---|---|---|---|
5–14 (42) | 15–24 (29) | 25–34 (29) | 35–44 (16) | 45+ (14) | |||
Weakness | M | 24 | 10 | 16 | 6 | 0 | 15.9 |
F | 8 | 14 | 4 | 4 | 0 | ||
Headache | M | 24 | 16 | 20 | 10 | 0 | 15.9 |
F | 12 | 9 | 0 | 0 | 0 | ||
Mouth rash | M | 10.4 | 8 | 15 | 17.4 | 0 | 14.7 |
F | 13.0 | 21.7 | 0 | 4.4 | 0 | ||
Cough | M | 7.2 | 12.7 | 16. 7 | 0 | 0 | 11.5 |
F | 13.1 | 16.7 | 0 | 0 | 0 | ||
Abdominal pain | M | 21.4 | 21.4 | 21.4 | 0 | 7.14 | 8.9 |
F | 0 | 21.4 | 7.1 | 0 | 0 | ||
Sore throat | M | 11.3 | 7.1 | 0 | 5.2 | 0 | 8.9 |
F | 21.4 | 15.7 | 0 | 7.1 | 0 | ||
Tongue Inflammation | M | 6.1 | 9.2 | 0 | 9.1 | 0 | 7.01 |
F | 7.3 | 16.4 | 0 | 0 | 0 | ||
Joint pain | M | 9.8 | 0 | 0 | 10 | 0 | 2.6 |
F | 0 | 6 | 0 | 0 | 0 | ||
Loss of appetite | M | 0 | 0 | 0 | 8 | 0 | 1.3 |
F | 0 | 0 | 0 | 0 | 0 |